Indomethacin → HCID 86678236, compound
Reaction equation
[NH2:1][CH2:2][CH2:3][S:4][S:5][CH2:6][CH2:7][NH:8][C:9](=[O:15])[O:10][C:11]([CH3:14])([CH3:13])[CH3:12].[CH3:16][C:17]1[N:25]([C:26]([C:28]2[CH:29]=[CH:30][C:31]([Cl:34])=[CH:32][CH:33]=2)=[O:27])[C:24]2[CH:23]=[CH:22][C:21]([O:35][CH3:36])=[CH:20][C:19]=2[C:18]=1[CH2:37][C:38](O)=[O:39].CCN=C=NCCCN(C)C>C(Cl)Cl>[Cl:34][C:31]1[CH:30]=[CH:29][C:28]([C:26]([N:25]2[C:24]3[C:19](=[CH:20][C:21]([O:35][CH3:36])=[CH:22][CH:23]=3)[C:18]([CH2:37][C:38]([NH:1][CH2:2][CH2:3][S:4][S:5][CH2:6][CH2:7][NH:8][C:9](=[O:15])[O:10][C:11]([CH3:12])([CH3:14])[CH3:13])=[O:39])=[C:17]2[CH3:16])=[O:27])=[CH:33][CH:32]=1Participants
5
Procedure
tert-Butyl 2-(2-(2-aminoethyl)disulfanyl)ethylcarbamate (150 mg, 0.595 mmol) was taken up in CH2C22 (10 mL) along with indomethacin (213 mg, 0.595 mmol) and EDCI (125 mg, 0.65 mmol). The resulting reaction mixture was stirred at room temperature for 18 h and diluted with CH2Cl2. The organic layer was washed with saturated aqueous NaHCO3, brine, dried over Na2SO4, filtered and concentrated under reduced pressure. The resulting residue was purified by chromatography (CH2Cl2) to afford 312 mg of tert-butyl 2-(2-(2-(2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetamido)ethyl)disulfanyl)ethylcarbamate (89% yield).
Workup
- customThe resulting reaction mixture
- washThe organic layer was washed with saturated aqueous NaHCO3, brine
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- customThe resulting residue was purified by chromatography (CH2Cl2)
Sources & evidence
- ORD record
- ord-966794dd17414aa2ba94d4f2a83ce2d0
- Source dataset
- uspto-grants-2015_12
- Patent number
- US09216224B2
Reaction notes
Loading…